Gene · 970
NIH grants2,135
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 2,135
Download this page as JSON| Grant | Title | CD70 papers | Newest fiscal year |
|---|---|---|---|
| ZIABC010661 | Vaccine and Drug Combination Therapy for Human Cancers | 1 | 2025 |
| ZIABC010675 | Development of a Carbohydrate Microarray | 1 | 2025 |
| ZIABC010740 | Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins | 1 | 2025 |
| ZIABC010816 | Adoptive cell therapy for malignant mesothelioma and other mesothelin expressing | 1 | 2025 |
| ZIABC010891 | Development of antibody engineering-based cancer therapies | 1 | 2025 |
| ZIABC010985 | Gene therapy of cancer | 1 | 2025 |
| ZIABC011007 | Functional genomic screens for molecular targets in cancer | 1 | 2025 |
| ZIABC011008 | Oncogenic mechanisms and molecular targets in lymphoma | 1 | 2025 |
| ZIABC011197 | Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells | 1 | 2025 |
| ZIABC011418 | Modulating Cancer Stem Cell Signaling in Thoracic Malignancies | 1 | 2025 |
| ZIABC011427 | Immunohistochemical and genomic analysis of tumors | 1 | 2025 |
| ZIABC011707 | The effect of therapeutics on mutated IDH1 cell lines and mice tumor models | 1 | 2025 |
| ZIABC011708 | Targeted and untargeted metabolomics in IDH1 mutated xenografts in mice | 1 | 2025 |
| ZIABC011709 | Metabolite profiling of patients blood, urine, cerebrospinal fluid and tissue | 1 | 2025 |
| ZIABC011710 | In vivo and in vitro metabolic flux analysis in preclinical mouse models | 1 | 2025 |
| ZIABC011711 | Develop RAMAN imaging to visualize metabolism in cell lines and tissue | 1 | 2025 |
| ZIABC011780 | Clinical development of mechanism-based lymphoma therapies | 1 | 2025 |
| ZIABC011823 | Development of Novel Approaches to Optimize CAR T-cell Therapies for B-cell Malignancies | 1 | 2025 |
| ZIABC011900 | Pilot Study of Avelumab in Thymic Epithelial Tumors | 1 | 2025 |
| ZIABC011914 | Molecular Biology of Lymphoma | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/grants?page=21